The proposed bill, known as the Chemical Abortion Safety Protocol Act, aims to establish specific protocols and requirements for the provision of abortion-inducing drugs in Nebraska. It includes definitions for key terms such as "abortion-inducing drug" and "adverse event," and mandates that physicians must conduct an in-person examination of the woman, verify her pregnancy, and assess for ectopic pregnancies before providing such drugs. Additionally, the bill requires follow-up visits to confirm the termination of pregnancy and assess for any adverse events, with detailed reporting requirements for physicians to submit to the Department of Health and Human Services.

Furthermore, the bill amends existing law regarding unprofessional conduct for physicians by adding violations of the Chemical Abortion Safety Protocol Act to the list of unprofessional conduct. It also includes a severability clause, ensuring that if any part of the act is deemed invalid, the remaining sections will still be enforceable. The original section of the law that is being amended will be repealed, and the act explicitly states that women who undergo an abortion will not be held liable for violations of this new protocol.

Statutes affected:
Introduced: 38-2021